跳至主要内容
临床试验/NCT00756600
NCT00756600已完成4 期

A Multi-site Randomised Controlled Trial Comparing Regional and General Anaesthesia for Effects on Neurodevelopmental Outcome and Apnoea in Infants

Boston Children's Hospital30 个研究点 分布在 7 个国家目标入组 643 人开始时间: 2006年10月23日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
643
试验地点
30
主要终点
Full Scale IQ Score

研究概览

简要总结

The primary purpose of the GAS study is to determine whether different types of anesthesia (Regional versus General) given to 720 infants undergoing inguinal hernia repair results in equivalent neurodevelopmental outcomes. The study also aims to describe the incidence of apnea in the post-operative period after both regional and general anesthesia for inguinal hernia repair in infants. This study is important as it will provide the greatest evidence for safety or toxicity of general anesthesia for human infants.

详细描述

This is a prospective, observer blind, multi-site, randomized, controlled, equivalence trial. The general anesthesia group will receive sevoflurane (intervention drug) for induction and maintenance of general anesthesia, dose up to 8% inspired for duration of procedure plus bupivacaine local anesthetic blockade (up to 2.5 mg per kg) administered via caudal or ilioinguinal nerve block. The airway can be maintained with a face mask, laryngeal mask or endotracheal tube, with or without neuromuscular blocking agents.

The regional group will have no sedative agent. The regional blockade may be with spinal alone, spinal block with caudal block, spinal with ilioinguinal block or caudal alone. The maximum dose of 2.5 mg per kg of bupivacaine can be used.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
— 至 60 Weeks(Child)
性别
All
接受健康志愿者

入选标准

  • Any infant scheduled for unilateral or bilateral inguinal hernia repair (with or without circumcision)
  • Any infant whose gestational age is 26 weeks or more (GA = 182 days)
  • Any infant whose post-menstrual age is up to 60 weeks (PMA = 426 days)

排除标准

  • Any child older than 60 weeks post-menstrual age
  • Any child born less than 26 weeks gestation
  • Any contraindication to general or spinal/caudal anesthesia (for example: neuromuscular disorder or coagulopathy)
  • Pre-operative ventilation immediately prior to surgery
  • Congenital heart disease that has required ongoing pharmacotherapy
  • Known chromosomal abnormality or any other known acquired or congenital abnormalities (apart from prematurity) which are likely to affect development
  • Children where follow-up would be difficult for geographic or social reasons
  • Families where English is not the primary language spoken at home
  • Known neurological injury such as cystic periventricular leukomalacia (PVL), or grade 3 or 4 intra ventricular hemorrhage (ICH) (+/- post hemorrhage ventricular dilation)
  • Previous exposure to volatile anesthesia or benzodiazepines as a neonate or in the third trimester in utero.

研究组 & 干预措施

1

Active Comparator

Regional Anesthesia

干预措施: Regional Anesthesia (Drug)

2

Active Comparator

General Anesthesia

干预措施: General Anesthesia (Drug)

结局指标

主要结局

Full Scale IQ Score

时间窗: At 5 years chronological age

The primary outcome will be the Wechsler Preschool and Primary Scale of Intelligence-Third Edition (WPPSI-III) full scale IQ score. Verbal, visuo-spatial and processing speed skills are incorporated into the Full Scale IQ score, which is indicative of general intellectual ability. Minimum score: 45 Maximum score:145 Higher scores are associated with higher IQ scores (better outcome). Note: Scale ranges represent estimates that are very likely to be accurate but which will be verified after access to the physical assessment booklets is restored. The current health situation prohibits the research team from verifying this information at the moment.

次要结局

  • Verbal IQ(At 5 years corrected age.)
  • Processing Speed Quotient(At 5 years corrected age)
  • Sentence Repetition Scaled Score(At 5 years chronological age)
  • Auditory Attention Combined Scaled Score(At 5 years corrected age)
  • Statue Scaled Score(At 5 years corrected age)
  • Affect Recognition Scaled Score(At 5 years corrected age)
  • Memory for Names and Memory for Names Delay(At 5 years corrected age)
  • Inhibition Combined Scaled Score(At 5 years corrected age)
  • Theory of Mind Scaled Score(At 5 years corrected age)
  • Speeded Naming Combined Scaled Score(At 5 years corrected age)
  • Fingertip Tapping Repetitions Scaled Score(At 5 years corrected age)
  • Fingertip Tapping Sequences Scaled Score(At 5 years corrected age)
  • Design Copy Process Total Scaled Score(At 5 years corrected age)
  • Performance IQ(At 5 years corrected age)
  • Word Generation Scaled Score(At 5 years corrected age)
  • Numerical Operations Standard Score(At 5 years chronological age)
  • Spelling Standard Score(At 5 years chronological age)
  • Numbers Total Scaled Score(At 5 years chronological age)
  • Word Lists 1 (Learning) Scaled Score(At 5 years chronological age)
  • Memory and Learning Word Lists II (Delayed) Scaled Score(At 5 years chronological age)
  • The Global Executive Composite (GEC) of the Behaviour Rating of Executive Function(At 5 years chronological age)
  • Word Reading Standard Score(At 5 years chronological age)
  • The Global Adaptive Composite (GAC) of the Adaptive Behavior Assessment System(At 5 years chronological age)
  • Total Problems Score(At 5 years chronological age)
  • Internalising Problems T Score(At 5 years chronological age)
  • Externalising Problems T Score(At 5 years chronological age)
  • Speech or Language Interventions(At 5 years chronological age)
  • Psychomotor Interventions(At 5 years chronological age)
  • Number of Participants With Global Developmental Delay(At 5 years chronological age)
  • Number of Participants With Attention Deficit Hyperactivity Disorder(At 5 years chronological age)
  • Number of Participants With Autism Spectrum Disorder(At 5 years chronological age)
  • Number of Participants With a Hearing Abnormality(At 5 years chronological age)
  • Number of Participants With a Visual Defect in Either Eye(At 5 years chronological age)
  • Number of Participants With a Hearing Aid(At 5 years chronological age)
  • Number of Participants Who Are Legally Blind(At 5 years chronological age)
  • Number of Participants Who Have Cerebral Palsy(At 5 years chronological age)
  • Parents' Awareness of Group Allocation(At 5 years chronological age)
  • Awareness of Group Allocation by Psychologist(At 5 years chronological age)
  • Awareness of Group Allocation by Pediatrician(At 5 years chronological age)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mary Ellen McCann

MD

Boston Children's Hospital

研究点 (30)

Loading locations...

相似试验